Moxifloxacin Sandoz

Moxifloxacin, the active ingredient in Moxifloxacin Sandoz, is a fluoroquinolone antibiotic presented as a tablet for oral use. It treats a range of bacterial infections, including pneumonia, sinusitis, bronchitis, and skin infections, in adult patients. GNH USA supplies Moxifloxacin Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacin is indicated for several bacterial infections that affect the respiratory tract and skin. - Community‑acquired pneumonia: eradicates the causative pathogens and improves clinical recovery. - Acute bacterial sinusitis: reduces sinus inflammation by eliminating the infecting organisms. - Acute exacerbations of chronic bronchitis: shortens symptom duration and prevents complications. - Skin and soft tissue infections: clears susceptible bacterial strains in cutaneous lesions. - Other susceptible bacterial infections: provides targeted therapy where the organism is known to be sensitive.

Moxifloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, occasionally watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Abdominal pain: cramping or discomfort. - Rash: mild skin irritation or redness.

Serious or Rare Side Effects: - Tendon rupture: sudden pain and loss of function, especially in the Achilles tendon. - QT interval prolongation: risk of cardiac arrhythmias. - Severe allergic reactions: anaphylaxis, angioedema, or Stevens‑Johnson syndrome. - Clostridioides difficile infection: severe colitis with diarrhea. - Hepatic toxicity: elevated liver enzymes or jaundice. - Photosensitivity: heightened skin reaction to sunlight.

Before prescribing Moxifloxacin, clinicians should consider patient‑specific factors and safety measures. - Assess renal function: adjust therapy if renal impairment is present. - Evaluate hypersensitivity: avoid in patients with known fluoroquinolone allergy. - Monitor for tendon pain: discontinue if signs of tendon inflammation appear. - Use cautiously in QT‑prolonging conditions: consider ECG monitoring. - Avoid concomitant use with corticosteroids when possible: increased risk of tendon injury. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Moxifloxacin can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce absorption of the drug. - Warfarin: may increase anticoagulant effect and bleeding risk. - Corticosteroids: heightened risk of tendon rupture. - Theophylline: increased plasma levels leading to toxicity. - Cyclosporine: elevated concentrations may cause nephrotoxicity.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase risk of central nervous system effects. - Oral contraceptives: reduced effectiveness, consider alternative contraception. - Diabetic agents: potential for altered glucose control. - Statins: increased risk of myopathy. - Antiarrhythmic drugs: possible additive QT prolongation.